NJ Biopharmaceuticals LLC, a provider of chemistry and biopharma services, is moving its headquarters from North Brunswick to Princeton, it announced this week.
NJ Bio said in a news release that it is moving to a 35,000-square-foot laboratory space at 350 Carter Road, a former Bristol-Myers Squibb site, by July 1 — and has plans to expand further at the location.
“Our expansion to this advanced facility demonstrates the rapid growth of NJ Bio in just over two years,” CEO and President Nareshkumar Jain said in a prepared statement. “This new location, well-equipped with the latest instruments and staffed by exceptional scientists, will ensure that NJ Bio continues to remain an outstanding partner to our clients, delivering high value and results for their most challenging research and development needs.”
The company noted it will also maintain its Bristol, Pennsylvania, facility, with plans to grow there, as well.